PetVivo Holdings, Inc.
No enriched coverage for $PETV in the last 7 days.
No SEC Form 4 filings for $PETV in the last 30 days.
See all $PETV insider activity →PetVivo Holdings, Inc. (PETV) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 TERMINATION AND SETTLEMENT AGREEMENT — VetStem, Inc. / PetVivo Holdings, Inc. — CONFIDENTIAL Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) the type of information that the r
PetVivo Holdings (OTCQX: PETV; OTCID: PETVW) reported Q4 and FY results for the year ended Mar. 31, 2026. Health Canada authorized Spryng with OsteoCushion for commercialization in Canada, with launch expected late July. Digital Landia launched a public beta of AgenticPet, and PetVivo.ai’s rollout showed 50%-90% lower acquisition costs; gross margins cited at 80%-90%.
PetVivo Holdings, Inc. (PETV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001512922 0001512922 2026-06-24 2026-06-24 0001512922 us-gaap:CommonStockMember 2026-06-24 2026-06-24 0001512922 PETV:WarrantsMember 2026-06-24 2026-06-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20
Recent PETV coverage spans corporate actions, insider activity and market movers.
Termination of the exclusive license and supply relationship likely reduces PetVivo’s near-term product revenue visibility and shifts inventory economics to VetStem.
Health Canada authorization and a planned late-July Canada launch are the clearest near-term commercialization catalysts for PETV.
Deal terms (share issuance, vesting/forfeiture milestones, and $5M minimum equity financing) create near-term event risk and potential dilution expectations for PETV.
Deal terms and share issuance create near-term valuation and financing/dilution questions, with execution risk until closing conditions are met.
Insider/institutional buying by a 10% owner can be read as incremental confidence, but the filing lacks price/valuation details and has limited standalone catalyst power.
alphai scores every news story that mentions PETV with an AI model for sentiment and relevance, and aggregates insider trades from PetVivo Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
PetVivo Holdings, Inc. (PETV) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 TERMINATION AND SETTLEMENT AGREEMENT — VetStem, Inc. / PetVivo Holdings, Inc. — CONFIDENTIAL Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) the type of information that the r
4 min readPetVivo Holdings (OTCQX: PETV; OTCID: PETVW) reported Q4 and FY results for the year ended Mar. 31, 2026. Health Canada authorized Spryng with OsteoCushion for commercialization in Canada, with launch expected late July. Digital Landia launched a public beta of AgenticPet, and PetVivo.ai’s rollout showed 50%-90% lower acquisition costs; gross margins cited at 80%-90%.
6 min readPetVivo Holdings, Inc. (PETV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001512922 0001512922 2026-06-24 2026-06-24 0001512922 us-gaap:CommonStockMember 2026-06-24 2026-06-24 0001512922 PETV:WarrantsMember 2026-06-24 2026-06-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20
6 min readPetVivo Holdings (OTCQX: PETV) said it agreed to acquire PiezoBioMembrane (PBM) via a merger, with PBM becoming a wholly owned subsidiary of Cosmeta Corp. PetVivo will issue 3,000,000 shares to PBM shareholders, with some consideration tied to milestones. The company expects PBM’s functional biomaterials and piezoelectric tech to expand IP and product development; closing is subject to customary conditions.
3 min readA.L. Sarroff Fund, LLC purchased 187,500 shares of PetVivo Holdings, Inc. (PETV) on 2026-06-09.
1 min readPetVivo Holdings, Inc. (PETV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Common Stock and Warrant Offering - $0.80 Per Unit $2,500,000 March 2026 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offerin
3 min readA.L. Sarroff Fund, LLC purchased 250,000 shares of PetVivo Holdings, Inc. (PETV) at $0.40 ($0.10M total) on 2026-05-22.
2 min readMINNEAPOLIS, April 16, 2025 ( GLOBE NEWSWIRE ) -- PetVivo Holdings, Inc. ( OTCQB: PETV. OTCPINK: PETVW ) ( "PetVivo" ) , an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it ...
2 min read
